Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

A genomic analysis of Mycobacterium immunogenum strain CD11_6 and its potential role in the activation of T cells against Mycobacterium tuberculosis.

Kaur G, Chander AM, Kaur G, Maurya SK, Nadeem S, Kochhar R, Bhadada SK, Agrewala JN, Mayilraj S.

BMC Microbiol. 2019 Mar 20;19(1):64. doi: 10.1186/s12866-019-1421-y.

2.

A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity.

Rai PK, Chodisetti SB, Zeng W, Nadeem S, Maurya SK, Pahari S, Janmeja AK, Jackson DC, Agrewala JN.

J Transl Med. 2017 Oct 6;15(1):201. doi: 10.1186/s12967-017-1301-x.

3.

A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis.

Bertholet S, Ireton GC, Ordway DJ, Windish HP, Pine SO, Kahn M, Phan T, Orme IM, Vedvick TS, Baldwin SL, Coler RN, Reed SG.

Sci Transl Med. 2010 Oct 13;2(53):53ra74. doi: 10.1126/scitranslmed.3001094.

4.

Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.

Cha SB, Kim WS, Kim JS, Kim H, Kwon KW, Han SJ, Eum SY, Cho SN, Shin SJ.

PLoS One. 2015 Oct 28;10(10):e0141577. doi: 10.1371/journal.pone.0141577. eCollection 2015.

5.

The BCGΔBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo.

Pedroza-Roldán C, Guapillo C, Barrios-Payán J, Mata-Espinosa D, Aceves-Sánchez Mde J, Marquina-Castillo B, Hernández-Pando R, Flores-Valdez MA.

Vaccine. 2016 Sep 14;34(40):4763-70. doi: 10.1016/j.vaccine.2016.08.035. Epub 2016 Aug 18.

PMID:
27546876
6.

Comparative Proteomic Profiling of Mycobacterium tuberculosis and the Thai Vaccine Strain Mycobacterium bovis Bacille Calmette-Guerin Tokyo172: Diverse Biomarker Candidates for Species Differentiation.

Kasempimolporn S, Premchaiporn P, Thaveekarn W, Boonchang S, Sitprija V.

J Glob Infect Dis. 2018 Oct-Dec;10(4):196-200. doi: 10.4103/jgid.jgid_149_17.

7.

A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis.

Rai PK, Chodisetti SB, Maurya SK, Nadeem S, Zeng W, Janmeja AK, Jackson DC, Agrewala JN.

J Transl Med. 2018 Oct 11;16(1):279. doi: 10.1186/s12967-018-1653-x.

8.

The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.

Ru H, Liu X, Lin C, Yang J, Chen F, Sun R, Zhang L, Liu J.

Front Cell Infect Microbiol. 2017 Jun 8;7:239. doi: 10.3389/fcimb.2017.00239. eCollection 2017.

9.

Comparison of the membrane proteome of virulent Mycobacterium tuberculosis and the attenuated Mycobacterium bovis BCG vaccine strain by label-free quantitative proteomics.

Gunawardena HP, Feltcher ME, Wrobel JA, Gu S, Braunstein M, Chen X.

J Proteome Res. 2013 Dec 6;12(12):5463-74. doi: 10.1021/pr400334k. Epub 2013 Oct 28.

10.

Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis.

Coler RN, Campos-Neto A, Ovendale P, Day FH, Fling SP, Zhu L, Serbina N, Flynn JL, Reed SG, Alderson MR.

J Immunol. 2001 May 15;166(10):6227-35.

11.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
12.

The ΔfbpA attenuated candidate vaccine from Mycobacterium tuberculosis, H37Rv primes for a stronger T-bet dependent Th1 immunity in mice.

Roche CM, Smith A, Lindsey DR, Meher A, Schluns K, Arora A, Armitige LY, Jagannath C.

Tuberculosis (Edinb). 2011 Dec;91 Suppl 1:S96-104. doi: 10.1016/j.tube.2011.10.018. Epub 2011 Nov 13.

13.

Vaccine efficacy of a Mycobacterium tuberculosis Beijing-specific proline-glutamic acid (PE) antigen against highly virulent outbreak isolates.

Kwon KW, Choi HH, Han SJ, Kim JS, Kim WS, Kim H, Kim LH, Kang SM, Park J, Shin SJ.

FASEB J. 2019 May;33(5):6483-6496. doi: 10.1096/fj.201802604R. Epub 2019 Feb 12.

PMID:
30753099
14.

The glycosylated Rv1860 protein of Mycobacterium tuberculosis inhibits dendritic cell mediated TH1 and TH17 polarization of T cells and abrogates protective immunity conferred by BCG.

Satchidanandam V, Kumar N, Jumani RS, Challu V, Elangovan S, Khan NA.

PLoS Pathog. 2014 Jun 12;10(6):e1004176. doi: 10.1371/journal.ppat.1004176. eCollection 2014 Jun. Erratum in: PLoS Pathog. 2014 Aug;10(8):e1004352.

15.
16.

Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.

Sun R, Skeiky YA, Izzo A, Dheenadhayalan V, Imam Z, Penn E, Stagliano K, Haddock S, Mueller S, Fulkerson J, Scanga C, Grover A, Derrick SC, Morris S, Hone DM, Horwitz MA, Kaufmann SH, Sadoff JC.

Vaccine. 2009 Jul 16;27(33):4412-23. doi: 10.1016/j.vaccine.2009.05.048. Epub 2009 Jun 2.

PMID:
19500523
17.

Immunogenicity and Vaccine Potential of InsB, an ESAT-6-Like Antigen Identified in the Highly Virulent Mycobacterium tuberculosis Beijing K Strain.

Kim WS, Kim H, Kwon KW, Cho SN, Shin SJ.

Front Microbiol. 2019 Feb 12;10:220. doi: 10.3389/fmicb.2019.00220. eCollection 2019.

18.

Exposure to human alveolar lining fluid enhances Mycobacterium bovis BCG vaccine efficacy against Mycobacterium tuberculosis infection in a CD8+ T-cell-dependent manner.

Moliva JI, Hossfeld AP, Canan CH, Dwivedi V, Wewers MD, Beamer G, Turner J, Torrelles JB.

Mucosal Immunol. 2018 May;11(3):968-978. doi: 10.1038/mi.2017.80. Epub 2017 Sep 20.

19.

Novel vaccine potential of Rv3131, a DosR regulon-encoded putative nitroreductase, against hyper-virulent Mycobacterium tuberculosis strain K.

Kwon KW, Kim WS, Kim H, Han SJ, Hahn MY, Lee JS, Nam KT, Cho SN, Shin SJ.

Sci Rep. 2017 Mar 8;7:44151. doi: 10.1038/srep44151.

20.

Prime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency.

Siddiqui KF, Amir M, Khan N, Rama Krishna G, Sheikh JA, Rajagopal K, Agrewala JN.

Clin Exp Immunol. 2015 Aug;181(2):286-96. doi: 10.1111/cei.12634. Epub 2015 Jun 3.

Supplemental Content

Support Center